JW Pharmaceutical Corp (001060):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:JW Pharmaceutical Corp (001060) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3485
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
JW Pharmaceutical Corp (JW Pharmaceutical), a subsidiary of JW Holdings Corp is a provider of generic drugs. The company develops and markets analgesics, antipyretics and cold remedy, antidote agents, antimicrobials, anticancer agents, and others. It offers multivitamins and antianemic agents, contact lens care and ophthalmic agents, antifungal agents, cardiovascular agents, and gastrointestinla agents. JW Pharmaceutical also offers topicals, amino acid solutions, flexible IV container, IV solutions, respiratory agents, obgy agents, nephrology agents, CNS, urology agents and diabetic agents. The company offers products for cardiovascular, gastrointestinal, nephrology or antianaemic, anticancer and neuropsychiatry. It operates through its production and manufacturing facilities in South Korea. JW Pharmaceutical is headquartered in Seoul, South Korea.

JW Pharmaceutical Corp (001060) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
JW Pharma Enters into Agreement with University of Pennsylvania 11
JW Pharmaceutical Enters into Co-Marketing Agreement with Ahn-Gook 12
JW Pharma Enters Into Agreement With Sanwa Kagaku Kenkyusho 13
JW Pharma Enters Into Co-Development Agreement With Pharmicell To Develop Stem Cell Therapy 14
Licensing Agreements 15
JW Pharma Enters into Licensing Agreement with EA Pharma 15
JW Pharma Enters into Licensing Agreement with Chugai Pharma 16
JW Pharma Enters into Licensing Agreement with Japan Tobacco 17
Equity Offering 18
JW Pharma Raises USD19 Million in Private Placement of Shares 18
Debt Offering 19
JW Pharma Completes Private Placement Of Bonds Due 2015 For US$27 Million 19
JW Pharma Completes Private Placement Of Bonds Due 2015 For US$17.8 Million 20
JW Pharmaceutical Corp – Key Competitors 21
JW Pharmaceutical Corp – Key Employees 22
JW Pharmaceutical Corp – Locations And Subsidiaries 23
Head Office 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
JW Pharmaceutical Corp, Deals By Therapy Area, 2012 to YTD 2018 8
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
JW Pharma Enters into Agreement with University of Pennsylvania 11
JW Pharmaceutical Enters into Co-Marketing Agreement with Ahn-Gook 12
JW Pharma Enters Into Agreement With Sanwa Kagaku Kenkyusho 13
JW Pharma Enters Into Co-Development Agreement With Pharmicell To Develop Stem Cell Therapy 14
JW Pharma Enters into Licensing Agreement with EA Pharma 15
JW Pharma Enters into Licensing Agreement with Chugai Pharma 16
JW Pharma Enters into Licensing Agreement with Japan Tobacco 17
JW Pharma Raises USD19 Million in Private Placement of Shares 18
JW Pharma Completes Private Placement Of Bonds Due 2015 For US$27 Million 19
JW Pharma Completes Private Placement Of Bonds Due 2015 For US$17.8 Million 20
JW Pharmaceutical Corp, Key Competitors 21
JW Pharmaceutical Corp, Key Employees 22

List of Figures
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[JW Pharmaceutical Corp (001060):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • G4S plc:企業のM&A・事業提携・投資動向
    G4S plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's G4S plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • South Jersey Industries, Inc. (SJI):電力:M&Aディール及び事業提携情報
    Summary South Jersey Industries, Inc. (SJI) is an energy services holding company that sources and supplies natural gas and electricity. It develops, owns, and operates on-site energy production facilities. The company provides wholesale commodity marketing and fuel management services; and also off …
  • Ducommun Incorporated:企業の戦略・SWOT・財務情報
    Ducommun Incorporated - Strategy, SWOT and Corporate Finance Report Summary Ducommun Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Eneva SA (ENEV3):電力:M&Aディール及び事業提携情報
    Summary Eneva SA (Eneva), formerly MPX Energia SA, is an integrated energy company. The company offers power generation, energy commercialization, and exploration and production of hydrocarbons and natural gas. Its power generation portfolio includes fossil fuels such as coal and natural gas, and re …
  • Greensmith Energy Management Systems LLC:企業の戦略的SWOT分析
    Greensmith Energy Management Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Trimedyne Inc:企業の戦略的SWOT分析
    Trimedyne Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • SmarTone Mobile Communications Ltd:企業の戦略的SWOT分析
    SmarTone Mobile Communications Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Cooper Energy Ltd (COE):企業の財務・戦略的SWOT分析
    Summary Cooper Energy Ltd (CEL) is an oil and gas exploration and production company that offers oil production programs. The company produces, and commercializes crude oil and natural gas products. It conducts exploration for oil and gas through a portfolio of prospective acreage in the Cooper, Otw …
  • Pierre & Vacances SA (VAC):企業の財務・戦略的SWOT分析
    Pierre & Vacances SA (VAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Gamma Medica Inc:医療機器:M&Aディール及び事業提携情報
    Summary Gamma Medica Inc (Gamma Medica), formerly Gamma Medica Ideas Inc is a medical device company that offers imaging solutions. The company designs, develops and manufactures imaging systems for clinical and pre-clinical applications. It offers lumagem, lumagem mbi workflow, lumagem procedure ov …
  • Hong Leong Asia Ltd (H22):企業の財務・戦略的SWOT分析
    Hong Leong Asia Ltd (H22) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Balkrishna Industries Ltd:企業の戦略・SWOT・財務情報
    Balkrishna Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Balkrishna Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Cermaq Group AS:企業の戦略的SWOT分析
    Cermaq Group AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • ALK-Abello AS (ALK B):企業の財務・戦略的SWOT分析
    ALK-Abello AS (ALK B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Spark New Zealand Ltd:企業の戦略・SWOT・財務分析
    Spark New Zealand Ltd - Strategy, SWOT and Corporate Finance Report Summary Spark New Zealand Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Landsvirkjun hf:企業の戦略的SWOT分析
    Landsvirkjun hf - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Umicore SA:企業の戦略・SWOT・財務情報
    Umicore SA - Strategy, SWOT and Corporate Finance Report Summary Umicore SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Georgia-Pacific LLC:企業の戦略・SWOT・財務分析
    Georgia-Pacific LLC - Strategy, SWOT and Corporate Finance Report Summary Georgia-Pacific LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Henkel AG & Co. KGaA:企業の戦略・SWOT・財務情報
    Henkel AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report Summary Henkel AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Senex Energy Ltd (SXY):企業の財務・戦略的SWOT分析
    Summary Senex Energy Ltd (Senex) is an independent upstream oil and gas company. It mainly focuses on the east coast of Australia. The company acquires, explores, and develops oil and gas assets in the Surat and Cooper basins. It owns significant acreage in the basins with operatorship over all of i …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆